Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era

Detalles Bibliográficos
Autores principales: Di Sanzo, Lorenzo, Scrivo, Rossana, Soriano, Enrique Roberto, Citera, Gustavo, Mysler, Eduardo, Wei, James Cheng-Chung, Ríos, Mario Humberto Cardiel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895950/
https://www.ncbi.nlm.nih.gov/pubmed/35252282
http://dx.doi.org/10.3389/fmed.2022.858817
_version_ 1784663038958239744
author Di Sanzo, Lorenzo
Scrivo, Rossana
Soriano, Enrique Roberto
Citera, Gustavo
Mysler, Eduardo
Wei, James Cheng-Chung
Ríos, Mario Humberto Cardiel
author_facet Di Sanzo, Lorenzo
Scrivo, Rossana
Soriano, Enrique Roberto
Citera, Gustavo
Mysler, Eduardo
Wei, James Cheng-Chung
Ríos, Mario Humberto Cardiel
author_sort Di Sanzo, Lorenzo
collection PubMed
description
format Online
Article
Text
id pubmed-8895950
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-88959502022-03-05 Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era Di Sanzo, Lorenzo Scrivo, Rossana Soriano, Enrique Roberto Citera, Gustavo Mysler, Eduardo Wei, James Cheng-Chung Ríos, Mario Humberto Cardiel Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-02-18 /pmc/articles/PMC8895950/ /pubmed/35252282 http://dx.doi.org/10.3389/fmed.2022.858817 Text en Copyright © 2022 Di Sanzo, Scrivo, Soriano, Citera, Mysler, Wei and Ríos. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Di Sanzo, Lorenzo
Scrivo, Rossana
Soriano, Enrique Roberto
Citera, Gustavo
Mysler, Eduardo
Wei, James Cheng-Chung
Ríos, Mario Humberto Cardiel
Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title_full Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title_fullStr Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title_full_unstemmed Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title_short Editorial: Drug Survival: Treatment of Rheumatic Diseases in the Biologic Era
title_sort editorial: drug survival: treatment of rheumatic diseases in the biologic era
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8895950/
https://www.ncbi.nlm.nih.gov/pubmed/35252282
http://dx.doi.org/10.3389/fmed.2022.858817
work_keys_str_mv AT disanzolorenzo editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT scrivorossana editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT sorianoenriqueroberto editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT citeragustavo editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT myslereduardo editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT weijameschengchung editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera
AT riosmariohumbertocardiel editorialdrugsurvivaltreatmentofrheumaticdiseasesinthebiologicera

Ejemplares similares